Concepedia

Heinz Hammerlindl

HH

Statistics

Publications

10

Citations

280

H-Index

10

Active since

2016

Affiliations

The University of Queensland(Current)

Translational Research Institute

University of California, San Francisco

The Wistar Institute

Princess Alexandra Hospital

Heinz Hammerlindl is an author at The University of Queensland specializing in oncology, molecular oncology, and medicine.

ORCID

Publications per year

2016–2025

10

Publications

10

Distinct histone modifications denote early stress-induced drug tolerance in cancer

Diego M. Marzese, Dinoop Ravindran Menon, Mitchell Stark et al. · Oncotarget · 2017 · 73 citations · Full text

, , +14

Notch4 Signaling Induces a Mesenchymal–Epithelial–like Transition in Melanoma Cells to Suppress Malignant Behaviors

Ehsan Bonyadi Rad, Heinz Hammerlindl, Christian Wels et al. · Cancer Research · 2016 · 54 citations · Full text

, , +17

Implantation of engineered adipocytes suppresses tumor progression in cancer models

Hai P. Nguyen, Kelly An, Yusuke Ito et al. · Nature Biotechnology · 2025 · 38 citations · Full text

, , +16

Small molecule in situ resin capture provides a compound first approach to natural product discovery

Alexander Bogdanov, Mariam N. Salib, Alexander B. Chase et al. · Nature Communications · 2024 · 24 citations · Full text

, , +15

Magnolol induces cell death through PI3K/Akt‐mediated epigenetic modifications boosting treatment of <i>BRAF‐</i> and <i>NRAS</i>‐mutant melanoma

Brinda Reddy Chinna Chowdary, Farzana Ahmed, Heinz Hammerlindl et al. · Cancer Medicine · 2019 · 21 citations · Full text

, , +17

1–5 of 10